Login / Signup

Pan-cancer analysis of LRRC59 with a focus on prognostic and immunological roles in hepatocellular carcinoma.

Boyu PanJun ChengWei TanXin WuQizhi FanLei FanMinghui JiangRong YuXiaoyun ChengYouwen Deng
Published in: Aging (2024)
LRRC59 emerges as a novel potential prognostic biomarker across malignancies, offering promise for anti-cancer drugs and immunotherapy.
Keyphrases
  • papillary thyroid
  • squamous cell
  • big data
  • young adults
  • risk assessment
  • childhood cancer
  • artificial intelligence